Sharda Cropchem (SCL) delivered solid Q1 FY27 with total revenue up 9% YoY to Rs. 1,074 Cr.

Agrochemicals grew 8% (Rs. 915 Cr), and Non-Agrochemicals soared 15% (Rs. 159 Cr). Geographically, NAFTA revenue jumped 33% and LATAM impressively rose 52%, balancing an 11% dip in Europe's agrochem sales.

Gross Profit increased 13% to Rs. 394 Cr, and EBITDA rose 25% to Rs. 178 Cr, boosting margins to 16.6%. However, reported PAT decreased 38% to Rs. 88.0 Cr due to significantly lower forex gains (Rs. 7.5 Cr vs. Rs. 73.1 Cr YoY). Excluding this, Profit Before Tax (PBT) actually climbed 16%. SCL's strategy focuses on strengthening its IP-driven, asset-light model.

Plans include building a stronger sales force for a 'factory-to-farmer' approach, expanding global distribution, and continuous investment in new product registrations.

The company also highlights improving operational efficiencies and maintaining financial discipline, reflected in a 10-day reduction in working capital.

This roadmap aims for sustainable growth and long-term value.